Single Cell Multi Omics Market Report 2025 (Global Edition)

Global Single Cell Multi Omics Market Report 2025 Market Size Split by Type Outlook: (Single-cell genomics, Single-cell proteomics, Single-cell transcriptomics, Single-cell metabolomics), by Applicati...

Single Cell Multi Omics Market Report Description

We have various report editions of Single Cell Multi Omics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Single Cell Multi-Omics Market

Leading companies in the single-cell multi-omics market are present and concentrate on product launches, strategic alliances, and technical innovation, which defines the competitive landscape. Companies that control the market include Fluidigm Corporation, Bio-Rad Laboratories, Illumina, and 10x Genomics. Newcomers are using developments in microfluidics and sequencing to obtain an advantage. Academic-industry partnerships are encouraging innovation even more and increasing the market's potential for expansion.

In November 2023, Illumina unveiled a cutting-edge liquid biopsy technique intended to provide thorough genomic analysis of solid tumors. (Source:https://investor.illumina.com/news/press-release-details/2023/Illumina-launches-advanced-liquid-biopsy-assay-to-enable-comprehensive-genomic-profiling-of-solid-tumors/default.aspx) In October 2022, Takara Bio USA, Inc. and BioExcel Diagnostic Tools, two innovative life science reagent and device companies, will create and validate a sophisticated, all-inclusive method for syndromic marker-based infectious illness diagnosis. Takara Bio USA, Inc. is a wholly-owned subsidiary of Takara Bio Inc. (Source: https://www.takarabio.com/about/in-the-news/takara-bio-usa-inc-and-bioexcel-diagnostics-partner-for-development-of-wide-coverage-infectious-disease-detection-panels?srsltid=AfmBOorForNnmi5sr3w-Dul9Cm1_imhVHgrRWv11gIapUuPIq16aSseJ) In May 2022, The CE-marked in vitro diagnostic TruSigh Oncology (TSO) Comprehensive (EU) test now has a companion diagnostic (CDx) indication, according to a statement from Illumina, Inc., a leader in DNA sequencing and array-based technologies worldwide. Cancer patients are diagnosed using this test. This recently announced single-test kit assesses many tumor genes and biomarkers to determine the exact molecular profile of a patient's malignancy. (Source: https://investor.illumina.com/news/press-release-details/2022/Illumina-Introduces-New-Pan-Cancer-Companion-Diagnostic-to-Match-Patients-with-Rare-Genetic-Mutations-to-Targeted-Therapy/default.aspx) In December 2021, Denovo Biopharma and Qiagen collaborated to offer a ground-breaking biomarker solution. To determine which patients with Denovo Genomic Marker 1 would be good candidates for treatment of diffuse large B-cell lymphoma, a common lymphoid disease, using Denovo's experimental cancer drug DB102TM, the companies intended to develop a blood-based companion diagnostic test through this collaboration. (Source: https://corporate.qiagen.com/newsroom/press-releases/press-release-details/2021/QIAGEN-and-Denovo-Biopharma-Partner-to-Develop-Companion-Diagnostic-Test-for-the-Treatment-of-Diffuse-Large-B-Cell-Lymphoma-DLBCL/default.aspx)

Top Companies Market Share in Single Cell Multi Omics Industry: (In no particular order of Rank)

• 1CellBio
• Celsee
• Inc
• 10X Genomics Inc
• GE LifeSciences
• QIAGEN N.V
• Illumina
• Inc
• Mission Bio
• Takara Bio
• NanoString Technologies Inc
• Fluxion Biosciences
• Fluidigm Corporation
• Bio-Rad Laboratories Inc
• BGI Genomics Co. Ltd.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Single Cell Multi-Omics Market

Which Region Dominates the Single Cell Multi-Omics Market in 2024?

According to Cognitive Market Research, North America currently dominates the Single Cell Multi-Omics market, and the region is expected to have significant growth during the projected period. Because of its strong emphasis on precision medicine, high research funding, and excellent healthcare infrastructure, North America is well-positioned to propel the growth of the single-cell multi-omics market. Leading academic institutions and biotech businesses in the area are making significant investments in cutting-edge technologies, including spatial transcriptomics and next-generation sequencing. Adoption is also being accelerated by the growing desire for individualized therapy and the increasing prevalence of chronic diseases, especially cancer. Government programs that fund genomics research and industry-academia partnerships also accelerate market expansion. North America is positioned as a major driver in the worldwide market due to the presence of important industry players and the availability of qualified people.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). This is due to rapid biotechnology innovations, increased research funding, and the growing desire for personalized medicine are all projected to propel the single-cell multi-omics market's growth in the Asia Pacific region. Significant advancements are aiding the adoption of single-cell technology in the pharmaceutical, healthcare, and genomic research sectors in nations like China, India, and Japan. The region's developing healthcare infrastructure and growing emphasis on precision medicine are driving market expansion. Government programs, partnerships with international biotech companies, and the rising incidence of chronic illnesses in the area also contribute to the market's robust growth trajectory.

The current report Scope analyzes Single Cell Multi Omics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Single Cell Multi Omics

According to Cognitive Market Research, the global Single Cell Multi-Omics market size was estimated at USD 4524.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1809.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Single Cell Multi-Omics market with a market size of USD 1427.93 million in 2024 and is projected to grow at a CAGR of 22.5% during the forecast period. In the U.S., there is strong financial support from institutions such as the NIH for biological research.
• The Canada Single Cell Multi-Omics market had a market share of USD 217.18 million in 2024 and is projected to grow at a CAGR of 23.5% during the forecast period. In Canada, government programs that fund research in personalized medicine and genomics.
• The Mexico Single Cell Multi-Omics market is projected to witness growth at a CAGR of 23.2% during the forecast period, with a market size of USD 164.69 million in 2024.

Europe Single Cell Multi Omics

According to Cognitive Market Research, the global Single Cell Multi-Omics market size was estimated at USD 4524.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1357.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 23.0% from 2024 to 2031.

• The United Kingdom Single Cell Multi-Omics market had a market share of USD 228.03 million in 2024 and is projected to grow at a CAGR of 23.8% during the forecast period. In the UK, there is a strong emphasis on cancer research and precision medicine.
• The France Single Cell Multi-Omics market is projected to witness growth at a CAGR of 22.2% during the forecast period, with a market size of USD 124.88 million in 2024.
• According to Cognitive Market Research, the German Single Cell Multi-Omics market size was valued at USD 268.76 million in 2024 and is projected to grow at a CAGR of 23.2% during the forecast period. In Germany, advanced research in developmental biology and stem cells.
• The Italy Single Cell Multi-Omics market is projected to witness growth at a CAGR of 22.4% during the forecast period, with a market size of USD 116.73 million in 2024.
• The Russia Single Cell Multi-Omics market is projected to witness growth at a CAGR of 22.0% during the forecast period, with a market size of USD 210.39 million in 2024.
• The Spain Single Cell Multi-Omics market is projected to witness growth at a CAGR of 22.1% during the forecast period with a market size of USD 111.30 million in 2024
• The Luxembourg Single Cell Multi-Omics market is projected to witness growth at a CAGR of 23.1% during the forecast period, with a market size of USD 42.08 million in 2024.
• The Portugal Single Cell Multi-Omics market is projected to witness growth at a CAGR of 22.8% during the forecast period, with a market size of USD 28.50 million in 2024.
• The Greece Single Cell Multi-Omics market is projected to witness growth at a CAGR of 23.3% during the forecast period, with a market size of USD 16.29 million in 2024.
• The Rest of Europe's Single Cell Multi-Omics market is projected to witness growth at a CAGR of 21.7% during the forecast period, with a market size of USD 210.39 million in 2024.

Asia Pacific Single Cell Multi Omics

According to Cognitive Market Research, the global Single Cell Multi-Omics market size was estimated at USD 4524.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1040.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 26.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Single Cell Multi-Omics market size was valued at USD 468.29 million in 2024 and is projected to grow at a CAGR of 26.0% during the forecast period. Single Cell Multi-Omics surged in China due to the Increased focus of the manufacturers and major market players.
• The Japan Single Cell Multi-Omics market is projected to witness growth at a CAGR of 25.0% during the forecast period, with a market size of USD 143.61 million in 2024.
• The India Single Cell Multi-Omics market had a market share of USD 124.88 million in 2024 and is projected to grow at a CAGR of 28.3% during the forecast period. In India, there is an Increased focus on understanding population-specific genetic variations.
• The South Korean Single Cell Multi-Omics market is projected to witness growth at a CAGR of 25.6% during the forecast period, with a market size of USD 104.06 million in 2024.
• The Australian Single Cell Multi-Omics market is projected to witness growth at a CAGR of 26.2% during the forecast period, with a market size of USD 54.11 million in 2024.
• The South East Asia Single Cell Multi-Omics market is projected to witness growth at a CAGR of 27.5% during the forecast period, with a market size of USD 71.80 million in 2024.
• The Rest of Asia Pacific Single Cell Multi-Omics market is projected to witness growth at a CAGR of 26.3% during the forecast period, with a market size of USD 73.89 million in 2024.

South America Single Cell Multi Omics

According to Cognitive Market Research, the global Single Cell Multi-Omics market size was estimated at USD 4524.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 226.23 million in 2024 and will grow at a compound annual growth rate (CAGR) of 23.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Single Cell Multi-Omics market size was valued at USD 96.82 million in 2024 and is projected to grow at a CAGR of 24.5% during the forecast period. Single Cell Multi-Omics flourished in Brazil due to expanding genomics research to understand local population genetics and tropical diseases.
• Argentina's Single Cell Multi-Omics market had a market share of USD 38.01 million in 2024 and is projected to grow at a CAGR of 24.8% during the forecast period. Argentina's increasing interest in disease research and agricultural genomics.
• Colombia Single Cell Multi-Omics market is projected to witness growth at a CAGR of 23.7% during the forecast period, with a market size of USD 20.13 million in 2024.
• Peru Single Cell Multi-Omics market is projected to witness growth at a CAGR of 24.1% during the forecast period, with a market size of USD 18.55 million in 2024.
• Chile Single Cell Multi-Omics market is projected to witness growth at a CAGR of 24.2% during the forecast period, with a market size of USD 16.29 million in 2024.
• The Rest of Latin America's Single Cell Multi-Omics market is projected to witness growth at a CAGR of 23.0% during the forecast period, with a market size of USD 36.42 million in 2024.

Middle East Single Cell Multi Omics

According to Cognitive Market Research, the global Single Cell Multi-Omics market size was estimated at USD 4524.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 90.49 million in 2024 and will grow at a compound annual growth rate (CAGR) of 24.2% from 2024 to 2031..

• The GCC Countries Single Cell Multi-Omics market is projected to witness growth at a CAGR of 25.0% during the forecast period, with a market size of USD 38.73 million in 2024. Single Cell Multi-Omics sales flourish due to the presence of major market players.
• The Egypt Single Cell Multi-Omics market is projected to witness growth at a CAGR of 24.5% during the forecast period, with a market size of USD 9.50 million in 2024.
• The South Africa Single Cell Multi-Omics market is projected to witness growth at a CAGR of 25.2% during the forecast period, with a market size of USD 14.30 million in 2024. Single Cell Multi-Omics sales flourished in South Africa due to the establishment of Omics technology research centers in partnership with multinational companies.
• The Turkey Single Cell Multi-Omics market is projected to witness growth at a CAGR of 23.7% during the forecast period, with a market size of USD 7.78 million in 2024.
• The Nigeria Single Cell Multi-Omics market is projected to witness growth at a CAGR of 23.3% during the forecast period, with a market size of USD 9.50 million in 2024.
• The Rest of the MEA Single Cell Multi-Omics market is projected to witness growth at a CAGR of 23.2% during the forecast period, with a market size of USD 10.68 million in 2024.

Single Cell Multi Omics Market Analysis

How are Segments Performing in the Global Single Cell Multi-Omics Market?

Single Cell Multi-Omics Market Type Segment Analysis

According to Cognitive Market Research, single-cell transcriptomics are likely to dominate the Single Cell Multi-Omics Market over the forecast period. In the single-cell multi-omics market, single-cell transcriptomics is a crucial application that focuses on analyzing gene expression at the individual cell level. It enables scientists to characterize RNA molecules, offering information on tissue-specific reactions, heterogeneity, and biological processes. This method looks at a single cell's transcriptome to find unusual cell populations, gene control systems, and cellular reactions to illnesses or stimuli. Because it provides a thorough understanding of the dynamics of gene expression in intricate biological systems, single-cell transcriptomics plays a crucial role in the advancement of immunology, cancer research, and personalized medicine.

Single-cell metabolomics is the fastest-growing segment in the Single Cell Multi-Omics Market. The analysis of metabolites within individual cells is the main emphasis of single-cell metabolomics, a crucial segment of the single-cell multi-omics market. This method allows for the high-resolution investigation of metabolic pathways, cellular energy state, and biochemical process regulation. Through the profiling of metabolites, including lipids, carbohydrates, and amino acids, single-cell metabolomics offers vital information about how cells react to changes in the environment, illnesses, and treatments. It is essential for understanding cellular heterogeneity, drug discovery, and cancer research, and it propels the development of precision medicines and customized medicine.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Single Cell Multi Omics Industry. Request a Free Sample PDF!

Single Cell Multi-Omics Market Application Segment Analysis

According to Cognitive Market Research, the oncology segment holds the largest share of the market. Oncology applications are essential for developing tailored treatment plans and furthering cancer research in the single-cell multi-omics industry. Tumor heterogeneity may be thoroughly analyzed thanks to single-cell multi-omics, which can identify different cell types within tumors, such as immune cells and cancer stem cells. Drug resistance, metastasis, and immune evasion pathways are revealed by this method. Researchers can develop targeted therapies, early detection biomarkers, and more effective personalized cancer treatments by combining genomics, transcriptomics, proteomics, and metabolomics. This approach improves patient outcomes by providing a thorough understanding of tumor biology.

In the Single Cell Multi-Omics Market, immunology has been expanding at a rapid pace. Immunology applications are essential for comprehending immune cell variety and function at a previously unheard-of level of detail in the single-cell multi-omics industry. By using this method, scientists may examine individual immune cells—such as T cells, B cells, and macrophages—and learn more about how they function in infections, autoimmune disorders, and immunological responses. Single-cell multi-omics helps identify immune cell subsets, monitor immune system activation, and find biomarkers for immunotherapy by integrating genomics, transcriptomics, proteomics, and metabolomics. This technique plays a key role in developing tailored immunotherapies and enhancing the management of diseases such as infections, autoimmune diseases, and cancer.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Single Cell Multi Omics Technique Outlook: Segment Analysis

Single Cell Multi-Omics Market Technique Segment Analysis

According to Cognitive Market Research, the single-cell analysis segment holds the largest market share. The need for comprehensive, high-resolution insights into cellular behavior is driving the single-cell multi-omics market's rapid growth in demand for single-cell analysis tools. Single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and mass spectrometry-based single-cell proteomics are among the highly sought-after techniques. Through the use of these techniques, individual cells can be examined at several omics levels, including transcriptomics, proteomics, metabolomics, and genomes. Applications in neurology, immunology, and cancer research are driving this demand as scientists look for cellular heterogeneity, disease causes, and targeted treatments for personalized medicine.

In the Single Cell Multi-Omics market, the rapidly growing sector is the single-cell isolation and dispensing category. In the single-cell multi-omics market, the necessity for accurate and effective cell analysis is driving an increase in demand for single-cell isolation and dispensing procedures. In order to isolate individual cells with the least amount of contamination, methods including droplet-based platforms, fluorescence-activated cell sorting (FACS), and microfluidics are highly sought after. These techniques are vital to producing high-quality single-cell samples necessary for multi-omics analyses. Scalable, high-throughput isolation and dispensing methods are becoming more and more necessary as applications in immunology, drug discovery, and cancer research increase. This is to ensure accurate and dependable single-cell profiling.

• Single-cell isolation and dispensing
• Single-cell analysis

Single Cell Multi Omics End User Outlook: Segment Analysis

Single Cell Multi-Omics Market End User Segment Analysis

According to Cognitive Market Research, the academic institutes segment dominates the market. In the single-cell multi-omics market, academic institutions are important end consumers that are vital to the advancement of research and innovation. These organizations investigate cellular heterogeneity, disease causes, and intricate biological processes using single-cell multi-omics technology. These technologies support academic research in fields such as immunology, neurology, oncology, and genetics, leading to advances in personalized medicine and drug development. Academic institutions are spearheading a large portion of the technological developments in single-cell multi-omics, which is driving the market's expansion and broadening its applications in a variety of scientific domains thanks to growing funding and partnerships with biotech businesses.

Pharmaceutical and biotech companies are projected to be the fastest-growing segment in the Single Cell Multi-Omics market. In the single-cell multi-omics industry, pharmaceutical and biotech firms are important end users that use these technologies for the development of personalized medicine, drug discovery, and biomarker identification. These businesses obtain a profound understanding of disease causes, cellular heterogeneity, and therapy responses by performing multi-omics analyses on individual cells. This makes it possible to find new drug targets, improve clinical trials, and create treatments that work better. The pharmaceutical and biotech industries are key growth drivers in precision medicine because of the ability to examine genomic, transcriptomic, proteomic, and metabolic data at single-cell resolution.

• Academic institutes
• Contract research organizations
• Pharmaceutical and biotech companies

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion